[go: up one dir, main page]

GB202010464D0 - Novel compounds and pharmaceutical compositions thereof for the treatment of diseases - Google Patents

Novel compounds and pharmaceutical compositions thereof for the treatment of diseases

Info

Publication number
GB202010464D0
GB202010464D0 GBGB2010464.2A GB202010464A GB202010464D0 GB 202010464 D0 GB202010464 D0 GB 202010464D0 GB 202010464 A GB202010464 A GB 202010464A GB 202010464 D0 GB202010464 D0 GB 202010464D0
Authority
GB
United Kingdom
Prior art keywords
diseases
treatment
pharmaceutical compositions
novel compounds
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2010464.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galapagos NV
Original Assignee
Galapagos NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galapagos NV filed Critical Galapagos NV
Priority to GBGB2010464.2A priority Critical patent/GB202010464D0/en
Publication of GB202010464D0 publication Critical patent/GB202010464D0/en
Priority to PCT/EP2021/068377 priority patent/WO2022008383A1/en
Priority to TW110124900A priority patent/TW202216678A/en
Priority to ARP210101931A priority patent/AR122929A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB2010464.2A 2020-07-08 2020-07-08 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases Ceased GB202010464D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB2010464.2A GB202010464D0 (en) 2020-07-08 2020-07-08 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
PCT/EP2021/068377 WO2022008383A1 (en) 2020-07-08 2021-07-02 Isoquinoline derivatives and pharmaceutical compositions thereof for the treatment of diseases
TW110124900A TW202216678A (en) 2020-07-08 2021-07-07 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
ARP210101931A AR122929A1 (en) 2020-07-08 2021-07-08 NEW COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2010464.2A GB202010464D0 (en) 2020-07-08 2020-07-08 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases

Publications (1)

Publication Number Publication Date
GB202010464D0 true GB202010464D0 (en) 2020-08-19

Family

ID=72050551

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2010464.2A Ceased GB202010464D0 (en) 2020-07-08 2020-07-08 Novel compounds and pharmaceutical compositions thereof for the treatment of diseases

Country Status (4)

Country Link
AR (1) AR122929A1 (en)
GB (1) GB202010464D0 (en)
TW (1) TW202216678A (en)
WO (1) WO2022008383A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115843272B (en) 2020-05-08 2025-07-18 哈利亚治疗公司 Inhibitors of NEK7 kinase
WO2022128850A1 (en) * 2020-12-16 2022-06-23 Galapagos Nv Novel isoquinoline derivatives and pharmaceutical copositions thereof for the treatment of diseases
EP4320127A1 (en) 2021-04-05 2024-02-14 Halia Therapeutics, Inc. Nek7 inhibitors
US20250177382A1 (en) 2021-04-22 2025-06-05 Halia Therapeutics, Inc. Nek7 inhibitors
WO2024059200A1 (en) 2022-09-14 2024-03-21 Halia Therapeutics, Inc. Nek7 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2853833A1 (en) * 2011-11-08 2013-05-16 Arena Pharmaceuticals, Inc. Modulators of the g protein-coupled mas receptor and the treatment of disorders related thereto
EP3209299A4 (en) * 2014-10-22 2018-04-04 The Board of Regents of The University of Texas System Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof

Also Published As

Publication number Publication date
WO2022008383A1 (en) 2022-01-13
AR122929A1 (en) 2022-10-19
TW202216678A (en) 2022-05-01

Similar Documents

Publication Publication Date Title
ZA202110597B (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
ZA202004025B (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
GB201907558D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
IL279397A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
GB202010464D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
IL286677A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
IL286688A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201911868D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
EP3877383A4 (en) Compounds and compositions for the treatment of respiratory diseases
IL286685A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
IL285751A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
IL287392A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of kidney diseases
EP4048678A4 (en) Compounds and compositions for the treatment of parasitic diseases
GB201907547D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of hepatitis B
GB201817343D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
GB201817344D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
GB201809836D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
HK40050861A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
GB202110230D0 (en) Compounds and pharmaceutical compositions for the treatment of metabolic disorders
GB202001420D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB202001421D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
HK40116900A (en) Pharmaceutical compositions for the treatment of visceral pain
IL313184A (en) Pharmaceutical compositions for the treatment of visceral pain
AU2021902146A0 (en) Compositions for the Treatment of Diseases and Conditions
HK40037090A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)